Aakash P Desai (Aakash Desai)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Current oncology reports

JCO oncology practice

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Mandy Jongbloed, Atulya Aman Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh, Dirk K M De Ruysscher, Lizza E L Hendriks, Aakash P Desai
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies. Current oncology reports (2024)
Aakash P Desai, Tadana A Vázquez, Keishla M Arce, Marcelo Corassa, Philip C Mack, Jhanelle E Gray, Bruna Pellini
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer. Cancers 16 (5) (2024)
Aakash P Desai, Tadana A Vázquez, Keishla M Arce, Marcelo Corassa, Philip C Mack, Jhanelle E Gray, Bruna Pellini
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer. Cancers 16 (5) (2024)
Mandy Jongbloed, Atulya Aman Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh, Dirk K M De Ruysscher, Lizza E L Hendriks, Aakash P Desai
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies. Current oncology reports 26 (1) (2024)
Mandy Jongbloed, Atulya Aman Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh, Dirk K M De Ruysscher, Lizza E L Hendriks, Aakash P Desai
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies. Current oncology reports 26 (1) (2024)
Mandy Jongbloed, Atulya Aman Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh, Dirk K M De Ruysscher, Lizza E L Hendriks, Aakash P Desai
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies. Current oncology reports 26 (1) (2024)
Mandy Jongbloed, Atulya Aman Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh, Dirk K M De Ruysscher, Lizza E L Hendriks, Aakash P Desai
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies. Current oncology reports 26 (1) (2024)
Mandy Jongbloed, Atulya Aman Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh, Dirk K M De Ruysscher, Lizza E L Hendriks, Aakash P Desai
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies. Current oncology reports 26 (1) (2024)
Aakash P Desai, Devika Das
Hear Me Out: Mitigating Cisplatin-Induced Ototoxicity. JCO oncology practice (2023)
Aakash P Desai, Christine M Lovly
Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology. Journal for immunotherapy of cancer 11 (6) (2023)
Tucker W Coston, Aakash P Desai, Hani M Babiker, Mohamad Bassam B Sonbol, Sakti Cjakrabarti, Amit Mahipal, Robert R McWilliams, Wen Wee Ma, Tanios S Bekaii-Saab, John A Stauffer, Jason S Starr
Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience. JCO precision oncology 7 (2023)
Aakash P Desai, Vivek Subbiah
Direct to patient clinical trials: One small step or a giant leap? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jacob J Adashek, Arjun K Menta, Neha K Reddy, Aakash P Desai, Jason Roszik, Vivek Subbiah
Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant Tumors. Molecular cancer therapeutics 21 (6) (2022)
Aakash P Desai, Caleb J Scheckel, Leah C Soderberg, Chelsee Jo Jensen, Jacob J Orme, Sri H Tella, Anuhya Kommalapati, Joshua C Pritchett, Nandita Khera, Amit Mahipal, Ronald S Go, null null
Economic Cost and Sustainability of Oral Therapies in Precision Oncology. JCO oncology practice 18 (8) (2022)
Joshua C Pritchett, Bijan J Borah, Aakash P Desai, Zhuoer Xie, Antoine N Saliba, Konstantinos Leventakos, Jordan D Coffey, Kristina K Pearson, Leigh L Speicher, Robert Orenstein, Abinash Virk, Ravindra Ganesh, Jonas Paludo, Thorvardur R Halfdanarson, Tufia C Haddad
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19. JCO oncology practice 17 (9) (2021)
Jacob J Adashek, Aakash P Desai, Alexander Y Andreev-Drakhlin, Jason Roszik, Gilbert J Cote, Vivek Subbiah
Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers. Molecular cancer therapeutics 20 (10) (2021)
Aakash P Desai, Narjust Florez, Gilberto de Lima Lopes
COVID-19 and Global Oncology: A Year in Review. JCO global oncology 7 (2021)
Aakash P Desai, Bhawna Sirohi, Aju Mathew
Clinical Trial Access in Low- and Middle-Income Countries: A Case Study on India. Cancer investigation 39 (9) (2021)
Aakash P Desai, Madhuri Chengappa, Ronald S Go, Thejaswi K Poonacha
Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019. Cancer 126 (16) (2020)